Review





Similar Products

90
GenScript corporation nucleotide sequences encoding the heavy chain variable region and the light chain variable region
Nucleotide Sequences Encoding The Heavy Chain Variable Region And The Light Chain Variable Region, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleotide sequences encoding the heavy chain variable region and the light chain variable region/product/GenScript corporation
Average 90 stars, based on 1 article reviews
nucleotide sequences encoding the heavy chain variable region and the light chain variable region - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Twist Bioscience scfv sequence (heavy chain linked to light chain variable regions) against human cd19, fmc63
Scfv Sequence (Heavy Chain Linked To Light Chain Variable Regions) Against Human Cd19, Fmc63, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scfv sequence (heavy chain linked to light chain variable regions) against human cd19, fmc63/product/Twist Bioscience
Average 90 stars, based on 1 article reviews
scfv sequence (heavy chain linked to light chain variable regions) against human cd19, fmc63 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Bioneer Corporation nucleotide sequences encoding the variable regions of anti-ctla-4 2c8 heavy chain (hc) and light chain (lc)
Nucleotide Sequences Encoding The Variable Regions Of Anti Ctla 4 2c8 Heavy Chain (Hc) And Light Chain (Lc), supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleotide sequences encoding the variable regions of anti-ctla-4 2c8 heavy chain (hc) and light chain (lc)/product/Bioneer Corporation
Average 90 stars, based on 1 article reviews
nucleotide sequences encoding the variable regions of anti-ctla-4 2c8 heavy chain (hc) and light chain (lc) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Thermo Fisher dna sequences for the variable heavy and light chain coding regions of tpl004_01_a11 and 2554_01_d11
Dna Sequences For The Variable Heavy And Light Chain Coding Regions Of Tpl004 01 A11 And 2554 01 D11, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna sequences for the variable heavy and light chain coding regions of tpl004_01_a11 and 2554_01_d11/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
dna sequences for the variable heavy and light chain coding regions of tpl004_01_a11 and 2554_01_d11 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology the ox40 agonist comprises a heavy chain variable region sequence and/or a light chain variable region sequence of antibody act35
The Ox40 Agonist Comprises A Heavy Chain Variable Region Sequence And/Or A Light Chain Variable Region Sequence Of Antibody Act35, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/the ox40 agonist comprises a heavy chain variable region sequence and/or a light chain variable region sequence of antibody act35/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
the ox40 agonist comprises a heavy chain variable region sequence and/or a light chain variable region sequence of antibody act35 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Twist Bioscience sequences of the variable regions of the heavy and light chains
Sequences Of The Variable Regions Of The Heavy And Light Chains, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequences of the variable regions of the heavy and light chains/product/Twist Bioscience
Average 90 stars, based on 1 article reviews
sequences of the variable regions of the heavy and light chains - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GenScript corporation l9 lineage pfcsp immunoglobulin heavy and light chain variable region sequences
(A) Ig heavy and light chain pairings matched to create normal mAbs <t>(L9,</t> F10, L9MRCA) and chimeric mAbs (L9HF10κ, F10HL9κ, D2HL9κ, D2HF10κ) used in this study. Each heavy and light chain’s divergence from germline is depicted. (B) Binding of various concentrations of indicated mAbs to rPfCSPFL (left), peptide 22 (NANPNVDPNANPNVD, middle), and (NANP)9 (right) measured by ELISA; optical density at 450 nm (OD450) is plotted. The NANP-preferring <t>PfCSP</t> mAb 317 and the anti-gp120 mAb VRC01 were included as positive and negative controls, respectively. (C) Binding response (nm) and apparent avidity (KDapp, nM) of indicated mAbs binding to peptide 22 determined through BLI. (D) Competition ELISA of indicated mAbs binding to rPfCSPFL and various concentrations of peptide 22 (rightmost bar) or variant peptides (other bars) where the indicated amino acid was mutated to alanine or serine. Area under the curve (AUC) is plotted. (E) SEC plots of indicated Fabs incubated with peptide 22 (Fabs alone, black peak; Fabs+pep22, blue peak). All data are representative of two independent experiments. See also Figure S2 and Table S1.
L9 Lineage Pfcsp Immunoglobulin Heavy And Light Chain Variable Region Sequences, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l9 lineage pfcsp immunoglobulin heavy and light chain variable region sequences/product/GenScript corporation
Average 90 stars, based on 1 article reviews
l9 lineage pfcsp immunoglobulin heavy and light chain variable region sequences - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Bio Basic Canada sequences of the variable regions of the heavy and light chains
(A) Ig heavy and light chain pairings matched to create normal mAbs <t>(L9,</t> F10, L9MRCA) and chimeric mAbs (L9HF10κ, F10HL9κ, D2HL9κ, D2HF10κ) used in this study. Each heavy and light chain’s divergence from germline is depicted. (B) Binding of various concentrations of indicated mAbs to rPfCSPFL (left), peptide 22 (NANPNVDPNANPNVD, middle), and (NANP)9 (right) measured by ELISA; optical density at 450 nm (OD450) is plotted. The NANP-preferring <t>PfCSP</t> mAb 317 and the anti-gp120 mAb VRC01 were included as positive and negative controls, respectively. (C) Binding response (nm) and apparent avidity (KDapp, nM) of indicated mAbs binding to peptide 22 determined through BLI. (D) Competition ELISA of indicated mAbs binding to rPfCSPFL and various concentrations of peptide 22 (rightmost bar) or variant peptides (other bars) where the indicated amino acid was mutated to alanine or serine. Area under the curve (AUC) is plotted. (E) SEC plots of indicated Fabs incubated with peptide 22 (Fabs alone, black peak; Fabs+pep22, blue peak). All data are representative of two independent experiments. See also Figure S2 and Table S1.
Sequences Of The Variable Regions Of The Heavy And Light Chains, supplied by Bio Basic Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequences of the variable regions of the heavy and light chains/product/Bio Basic Canada
Average 90 stars, based on 1 article reviews
sequences of the variable regions of the heavy and light chains - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AbbVie Inc sequences of the variable regions of the heavy and light chains
(A) Ig heavy and light chain pairings matched to create normal mAbs <t>(L9,</t> F10, L9MRCA) and chimeric mAbs (L9HF10κ, F10HL9κ, D2HL9κ, D2HF10κ) used in this study. Each heavy and light chain’s divergence from germline is depicted. (B) Binding of various concentrations of indicated mAbs to rPfCSPFL (left), peptide 22 (NANPNVDPNANPNVD, middle), and (NANP)9 (right) measured by ELISA; optical density at 450 nm (OD450) is plotted. The NANP-preferring <t>PfCSP</t> mAb 317 and the anti-gp120 mAb VRC01 were included as positive and negative controls, respectively. (C) Binding response (nm) and apparent avidity (KDapp, nM) of indicated mAbs binding to peptide 22 determined through BLI. (D) Competition ELISA of indicated mAbs binding to rPfCSPFL and various concentrations of peptide 22 (rightmost bar) or variant peptides (other bars) where the indicated amino acid was mutated to alanine or serine. Area under the curve (AUC) is plotted. (E) SEC plots of indicated Fabs incubated with peptide 22 (Fabs alone, black peak; Fabs+pep22, blue peak). All data are representative of two independent experiments. See also Figure S2 and Table S1.
Sequences Of The Variable Regions Of The Heavy And Light Chains, supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sequences of the variable regions of the heavy and light chains/product/AbbVie Inc
Average 90 stars, based on 1 article reviews
sequences of the variable regions of the heavy and light chains - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Sangon Biotech gene sequences encoding humanized heavy chain and light chain variable regions
(A) Ig heavy and light chain pairings matched to create normal mAbs <t>(L9,</t> F10, L9MRCA) and chimeric mAbs (L9HF10κ, F10HL9κ, D2HL9κ, D2HF10κ) used in this study. Each heavy and light chain’s divergence from germline is depicted. (B) Binding of various concentrations of indicated mAbs to rPfCSPFL (left), peptide 22 (NANPNVDPNANPNVD, middle), and (NANP)9 (right) measured by ELISA; optical density at 450 nm (OD450) is plotted. The NANP-preferring <t>PfCSP</t> mAb 317 and the anti-gp120 mAb VRC01 were included as positive and negative controls, respectively. (C) Binding response (nm) and apparent avidity (KDapp, nM) of indicated mAbs binding to peptide 22 determined through BLI. (D) Competition ELISA of indicated mAbs binding to rPfCSPFL and various concentrations of peptide 22 (rightmost bar) or variant peptides (other bars) where the indicated amino acid was mutated to alanine or serine. Area under the curve (AUC) is plotted. (E) SEC plots of indicated Fabs incubated with peptide 22 (Fabs alone, black peak; Fabs+pep22, blue peak). All data are representative of two independent experiments. See also Figure S2 and Table S1.
Gene Sequences Encoding Humanized Heavy Chain And Light Chain Variable Regions, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene sequences encoding humanized heavy chain and light chain variable regions/product/Sangon Biotech
Average 90 stars, based on 1 article reviews
gene sequences encoding humanized heavy chain and light chain variable regions - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


(A) Ig heavy and light chain pairings matched to create normal mAbs (L9, F10, L9MRCA) and chimeric mAbs (L9HF10κ, F10HL9κ, D2HL9κ, D2HF10κ) used in this study. Each heavy and light chain’s divergence from germline is depicted. (B) Binding of various concentrations of indicated mAbs to rPfCSPFL (left), peptide 22 (NANPNVDPNANPNVD, middle), and (NANP)9 (right) measured by ELISA; optical density at 450 nm (OD450) is plotted. The NANP-preferring PfCSP mAb 317 and the anti-gp120 mAb VRC01 were included as positive and negative controls, respectively. (C) Binding response (nm) and apparent avidity (KDapp, nM) of indicated mAbs binding to peptide 22 determined through BLI. (D) Competition ELISA of indicated mAbs binding to rPfCSPFL and various concentrations of peptide 22 (rightmost bar) or variant peptides (other bars) where the indicated amino acid was mutated to alanine or serine. Area under the curve (AUC) is plotted. (E) SEC plots of indicated Fabs incubated with peptide 22 (Fabs alone, black peak; Fabs+pep22, blue peak). All data are representative of two independent experiments. See also Figure S2 and Table S1.

Journal: Cell reports

Article Title: The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

doi: 10.1016/j.celrep.2022.110367

Figure Lengend Snippet: (A) Ig heavy and light chain pairings matched to create normal mAbs (L9, F10, L9MRCA) and chimeric mAbs (L9HF10κ, F10HL9κ, D2HL9κ, D2HF10κ) used in this study. Each heavy and light chain’s divergence from germline is depicted. (B) Binding of various concentrations of indicated mAbs to rPfCSPFL (left), peptide 22 (NANPNVDPNANPNVD, middle), and (NANP)9 (right) measured by ELISA; optical density at 450 nm (OD450) is plotted. The NANP-preferring PfCSP mAb 317 and the anti-gp120 mAb VRC01 were included as positive and negative controls, respectively. (C) Binding response (nm) and apparent avidity (KDapp, nM) of indicated mAbs binding to peptide 22 determined through BLI. (D) Competition ELISA of indicated mAbs binding to rPfCSPFL and various concentrations of peptide 22 (rightmost bar) or variant peptides (other bars) where the indicated amino acid was mutated to alanine or serine. Area under the curve (AUC) is plotted. (E) SEC plots of indicated Fabs incubated with peptide 22 (Fabs alone, black peak; Fabs+pep22, blue peak). All data are representative of two independent experiments. See also Figure S2 and Table S1.

Article Snippet: L9 lineage PfCSP immunoglobulin heavy and light chain variable region sequences , GenScript , GenBank Accession Numbers MZ686952 – MZ686956.

Techniques: Binding Assay, Enzyme-linked Immunosorbent Assay, Variant Assay, Incubation

(A) Left: binding of various concentrations of indicated mAbs to Pb-PfCSP-SPZ determined by flow cytometry; median fluorescence intensity (MFI) of mAb-bound SPZ is plotted. Mean and standard error of the mean (SEM) MFI values from four independent experiments are shown except for L9MRCA, which was from two experiments. Right: area under the curve (AUC) and SEM values calculated from the MFI plots. (B) Percentage (%) of SPZ undergoing the CSPR after incubation with 50 μg/mL of indicated mAb for 15 min. Bar graphs show the mean and SEM from six independent experiments. (C) Percentage of non-motile SPZ after incubation with 25 μg/mL of indicated mAb for 15 min. Bar graphs show the mean and SEM from two independent experiments. (B-C): P-values reflect comparisons between L9κ-containing mAbs and their F10κ-containing counterparts using Fisher’s exact test. (D) Reduction in parasite bioluminescence (total flux, photons/sec) in the livers of mice (n=15/group; data pooled from three independent experiments indicated by squares, circles, and triangles) mediated by 100 μg of indicated mAbs administered 2 hrs before IV challenge with 2,000 Pb-PfCSP-SPZ. P-values reflect comparisons between L9κ-containing mAbs and their F10κ-containing counterparts using the two-tailed Mann–Whitney test. (E) Survival curves of mice (n=7/group) challenged with five infected mosquito bites 24 hrs after passive transfer of 300 μg of indicated mAb.

Journal: Cell reports

Article Title: The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

doi: 10.1016/j.celrep.2022.110367

Figure Lengend Snippet: (A) Left: binding of various concentrations of indicated mAbs to Pb-PfCSP-SPZ determined by flow cytometry; median fluorescence intensity (MFI) of mAb-bound SPZ is plotted. Mean and standard error of the mean (SEM) MFI values from four independent experiments are shown except for L9MRCA, which was from two experiments. Right: area under the curve (AUC) and SEM values calculated from the MFI plots. (B) Percentage (%) of SPZ undergoing the CSPR after incubation with 50 μg/mL of indicated mAb for 15 min. Bar graphs show the mean and SEM from six independent experiments. (C) Percentage of non-motile SPZ after incubation with 25 μg/mL of indicated mAb for 15 min. Bar graphs show the mean and SEM from two independent experiments. (B-C): P-values reflect comparisons between L9κ-containing mAbs and their F10κ-containing counterparts using Fisher’s exact test. (D) Reduction in parasite bioluminescence (total flux, photons/sec) in the livers of mice (n=15/group; data pooled from three independent experiments indicated by squares, circles, and triangles) mediated by 100 μg of indicated mAbs administered 2 hrs before IV challenge with 2,000 Pb-PfCSP-SPZ. P-values reflect comparisons between L9κ-containing mAbs and their F10κ-containing counterparts using the two-tailed Mann–Whitney test. (E) Survival curves of mice (n=7/group) challenged with five infected mosquito bites 24 hrs after passive transfer of 300 μg of indicated mAb.

Article Snippet: L9 lineage PfCSP immunoglobulin heavy and light chain variable region sequences , GenScript , GenBank Accession Numbers MZ686952 – MZ686956.

Techniques: Binding Assay, Flow Cytometry, Fluorescence, Incubation, Two Tailed Test, MANN-WHITNEY, Infection

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

doi: 10.1016/j.celrep.2022.110367

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: L9 lineage PfCSP immunoglobulin heavy and light chain variable region sequences , GenScript , GenBank Accession Numbers MZ686952 – MZ686956.

Techniques: Virus, Recombinant, Construct, SYBR Green Assay, Staining, Expressing, Crystallization Assay, Luciferase, Amplification, Software, In Vivo Imaging, Fluorescence, Microscopy